Endothelial senescent-cell-specific clearance alleviates metabolic dysfunction in obese mice

Masayoshi Suda1, Selim Chaib2, Larissa G P Langhi Prata2

  • 1Center for Advanced Gerotherapeutics, Cedars-Sinai Medical Center, Pacific Design Center, 8687 Melrose Avenue, West Hollywood, CA 90048, USA; Division of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Cell Metabolism
|November 21, 2025
PubMed

Insights

Senescent endothelial cells drive metabolic dysfunction and inflammation. Eliminating these cells improves metabolic health, offering a potential therapeutic strategy for metabolic diseases.

Area of Science:

  • Cellular senescence
  • Endothelial cell biology
  • Metabolic disorders

Background:

  • Cellular senescence contributes to age-related diseases, including metabolic dysfunction.
  • The role of senescent endothelial cells in metabolic disorders is not well understood.
  • Previous work showed senolytic drugs alleviate obesity-induced metabolic dysfunction.

Purpose of the Study:

  • To investigate the contribution of senescent endothelial cells to metabolic disorders.
  • To determine if selective elimination of senescent endothelial cells can ameliorate metabolic dysfunction.
  • To explore senescent endothelial cells as a therapeutic target for metabolic disease.

Main Methods:

  • Generated Tie2-Cre;p16Ink4a-LOX-ATTAC mice for inducible, selective elimination of senescent endothelial cells.
  • Administered senolytic drug fisetin to obese mice and mice transplanted with senescent endothelial cells.
  • Assessed adipose tissue inflammation and metabolic parameters, including glucose metabolism.

Main Results:

  • Targeted removal of senescent endothelial cells from obese mice reduced inflammation and improved metabolic dysfunction.
  • Transplantation of senescent endothelial cells into lean mice induced adipose tissue inflammation and metabolic dysfunction.
  • Fisetin treatment reduced senescent endothelial cell burden and improved glucose metabolism in obese or senescent cell-transplanted mice.

Conclusions:

  • Senescent endothelial cells play a critical role in driving metabolic dysfunction.
  • Selective elimination of senescent endothelial cells is a promising therapeutic strategy for metabolic diseases.
  • Targeting senescent endothelial cells with senolytics like fisetin can improve metabolic health.